反応式
[CH3:1][C:2]1[C:3]([C:22](O)=[O:23])=[CH:4][C:5]2[C:6]3[N:15]([CH:16]4[CH2:21][CH2:20][O:19][CH2:18][CH2:17]4)[N:14]=[CH:13][C:7]=3[C:8](=[O:12])[NH:9][C:10]=2[CH:11]=1.[NH2:25][CH2:26][CH2:27][N:28]1[CH2:33][CH2:32][CH2:31][CH2:30][CH2:29]1.CCN(C(C)C)C(C)C.CN(C(ON1N=NC2C=CC=NC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F>CN(C=O)C>[CH3:1][C:2]1[C:3]([C:22]([NH:25][CH2:26][CH2:27][N:28]2[CH2:33][CH2:32][CH2:31][CH2:30][CH2:29]2)=[O:23])=[CH:4][C:5]2[C:6]3[N:15]([CH:16]4[CH2:21][CH2:20][O:19][CH2:18][CH2:17]4)[N:14]=[CH:13][C:7]=3[C:8](=[O:12])[NH:9][C:10]=2[CH:11]=1参加物
6
反応物 4
HCID 33944N-(2-Aminoethyl)piperidine
HCID 81531Diisopropylethylamine
HCID 9886157Methanaminium, N-((dimethylamino)(3H-1,2,3-triazolo(4,5-b)pyridin-3-yloxy)methylene)-N-methyl-, hexafluorophosphate(1-) (1:1)
HCID 1363368547-methyl-4-oxo-1-(tetrahydro-2H-pyran-4-yl)-4,5-dihydro-1H-pyrazolo[4,3-c]quinoline-8-carboxylic acid生成物 1
試薬・触媒・溶媒 1
実験手順
To a mixture of 8.2 mg of 7-methyl-4-oxo-1-(tetrahydro-2H-pyran-4-yl)-4,5-dihydro-1H-pyrazolo[4,3-c]quinoline-8-carboxylic acid, 3.8 mg of 1-(2-aminoethyl)piperidine, 13.1 μL of DIPEA, and 0.4 mL of DMF was added a mixture of 9.8 mg of HATU and 0.1 mL of DMF, followed by stirring at room temperature overnight. The reaction mixture was purified by preparative HPLC (methanol/0.1% aqueous formic acid solution) to obtain 3.6 mg of 7-methyl-4-oxo-N-[2-(piperidin-1-yl)ethyl]-1-(tetrahydro-2H-pyran-4-yl)-4,5-dihydro-1H-pyrazolo[4,3-c]quinoline-8-carboxamide.
後処理
- additionwas added
- customThe reaction mixture was purified by preparative HPLC (methanol/0.1% aqueous formic acid solution)
出典と根拠
- ORDレコード
- ord-2ba3deb513e642d98cbf40b78e3620ce
- 出典データセット
- uspto-grants-2014_09
- 特許番号
- US08822448B2
関連ノート
読み込み中…